Abstract
Type I interferon responses have been considered detrimental to host protection in tuberculosis (TB). We provide novel data to challenge this paradigm, derived from transcriptional profiling of human in vivo immune responses to discover associations with radiographic disease severity in pulmonary TB, combined with mechanistic studies to test causality for observed associations using a zebrafish larval mycobacterial infection model. Type I interferon activity in tissue samples from the site of a standardised mycobacterial challenge, the tuberculin skin test, was associated with less severe human TB disease. Abrogation of type I interferon signalling, by CRISPR-mediated mutagenesis of stat2, led to increased burden and dissemination of Mycobacterium marinum infection in zebrafish larvae. The mechanism for increased severity of mycobacterial infection in zebrafish involves reduced recruitment of myeloid cells required to restrict bacterial growth. Our data support a clear host protective role for type I interferon responses in mycobacterial infection, with potential applications for risk-stratification of adverse outcomes and development of a host-directed therapy to mitigate against severe disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GST is supported by a UK MRC Clinician Scientist Fellowship (MR/N007727/1). MN is supported by the Wellcome Trust (207511/Z/17/Z). PME is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (105570/Z/14/Z). J-PL is supported by Fondation pour la Recherche Medicale (grant EQU202203014646). MN and GST are also supported by NIHR Biomedical Research Centre Funding to University College Hospitals NHS Foundation Trust and University College London. This research was funded in whole, or in part, by the Wellcome Trust [207511/Z/17/Z, 105570/Z/14/Z]. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The London Bloomsbury Research Ethics Committee gave ethical approval for this work (16/LO/0776).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Results section updated to include analysis of the peripheral blood transcriptome in this cohort of individuals with pulmonary TB. An additional author added. Supplemental files updated.
Data Availability
Human TST RNAseq data and peripheral blood RNAseq data from healthy individuals are already available in the ArrayExpress repository under accession numbers E-MTAB-6816 and E-MTAB-10022, respectively. Human peripheral blood data from TB patients and zebrafish RNAseq data will be made available in ArrayExpress at the time of peer reviewed publication of the manuscript. Source data for figure panels with fewer than 20 data points are available in Data S1.
https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6816
https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-10022
